NLM Digital Collections

Search

Start Over Subjects Administration, Oral ✖Remove constraint Subjects: Administration, Oral Publication Year 2000 to 2024 ✖Remove constraint Publication Year: <span class="from" data-blrl-begin="2000">2000</span> to <span class="to" data-blrl-end="2024">2024</span>

11. Compounding certain ibuprofen oral suspension products under section 503B of the Federal Food, Drug, and Cosmetic Act

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, April 2023
Subject(s):
Administration, Oral
Drug Compounding -- methods
Drug Compounding -- standards
Drug Industry
Government Regulation
Ibuprofen
Legislation, Drug
Suspensions
United States
United States. Food and Drug Administration
United States.

12. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value : final evidence report

Author(s):
Lin, Grace A., author
Whittington, Melanie D., author
Nikitin, Dmitriy, author
Agboola, Foluso, author
McKenna, Avery, author
Herron-Smith, Serina, author
Pearson, Steven D, author
Campbell, Jonathan D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 21, 2023
Subject(s):
Antibodies, Monoclonal -- therapeutic use
Multiple Sclerosis, Relapsing-Remitting -- drug therapy
Treatment Outcome
Administration, Oral
United States